Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, UroGen Pharma Ltd’s stock clocked out at $13.79, down -3.57% from its previous closing price of $14.3. In other words, the price has decreased by -$3.57% from its previous closing price. On the day, 2.48 million shares were traded. URGN stock price reached its highest trading level at $14.5425 during the session, while it also had its lowest trading level at $13.36.
Ratios:
To gain a deeper understanding of URGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.47 and its Current Ratio is at 5.65.
On April 16, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $23.Scotiabank initiated its Sector Outperform rating on April 16, 2025, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 09 ’25 when Schoenberg Mark sold 5,162 shares for $7.37 per share. The transaction valued at 38,044 led to the insider holds 153,378 shares of the business.
Schoenberg Mark bought 5,162 shares of URGN for $38,044 on Jun 09 ’25. On Jan 31 ’25, another insider, Schoenberg Mark, who serves as the Chief Medical Officer of the company, sold 4,551 shares for $11.14 each. As a result, the insider received 50,698 and left with 145,666 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, URGN now has a Market Capitalization of 635822400 and an Enterprise Value of 566294720. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.92. Its current Enterprise Value per Revenue stands at 6.164 whereas that against EBITDA is -5.313.
Stock Price History:
The Beta on a monthly basis for URGN is 0.53, which has changed by -0.19732249 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, URGN has reached a high of $18.15, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is 50.15%, while the 200-Day Moving Average is calculated to be 26.26%.
Shares Statistics:
It appears that URGN traded 2.71M shares on average per day over the past three months and 7109370 shares per day over the past ten days. A total of 46.10M shares are outstanding, with a floating share count of 39.62M. Insiders hold about 14.08% of the company’s shares, while institutions hold 96.91% stake in the company. Shares short for URGN as of 1748563200 were 3915278 with a Short Ratio of 1.44, compared to 1745971200 on 5015969. Therefore, it implies a Short% of Shares Outstanding of 3915278 and a Short% of Float of 8.67.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
